跳至主要内容
临床试验/NCT05118009
NCT05118009已完成不适用

Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE)

National Defense Medical Center, Taiwan2 个研究点 分布在 1 个国家目标入组 43,176 人开始时间: 2022年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43,176
试验地点
2
主要终点
E2C (ECG to coronary angiography) time

研究概览

简要总结

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based supporting tool for improving the diagnosis and management of ST-elevation myocardial infarction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients in emergency department or inpatient department.
  • Patients recieved at least 1 ECG examination.

排除标准

  • The patients recieved ECG at the period of inactive AI-ECG system.

结局指标

主要结局

E2C (ECG to coronary angiography) time

时间窗: Within 6 hours

Time from ECG to activation of coronary angiography for STEMI patients.

次要结局

  • Highest concentration of high-sensitivity cardiac troponin I(Within 3 days)
  • D2C (Door to coronary angiography) time(Within 6 hours)
  • Ejection fractrion(Within 3 days)
  • Highest concentration of creatine kinase(Within 3 days)
  • Length of hospitalization(Within 28 days)
  • Number of CAG event(Within 6 hours)
  • D2B (Door to Balloon Time) time(Within 6 hours)
  • E2B (ECG to primary percutaneous coronary intervention) time(Within 6 hours)

研究者

发起方
National Defense Medical Center, Taiwan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chin Lin

Associate Professor

National Defense Medical Center, Taiwan

研究点 (2)

Loading locations...

相似试验

Artificial Intelligence Based Rapid Identification... | 临床试验